Loss of Fas (CD95/APO-1) regulatory function is an important step in early MALT-type lymphoma development

被引:33
作者
Seeberger, H [1 ]
Starostik, P [1 ]
Schwarz, S [1 ]
Knörr, C [1 ]
Kalla, J [1 ]
Ott, G [1 ]
Müller-Hermelink, HK [1 ]
Greiner, A [1 ]
机构
[1] Univ Wurzburg, Inst Pathol, D-97080 Wurzburg, Germany
关键词
D O I
10.1038/labinvest.3780310
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Fas(CD95, APO-1) mutations were found in autoimmune diseases and some lymphomas, suggesting impairment of Fas-mediated cell death signaling that may cause tumor development. Because mucosa-associated lymphoid tissue (MALT)-type lymphoma B cells recognize autoantigens and proliferate in response to antigen and T cell-mediated signals, it is suggestive that autoreactive B cell lymphoma precursor cells may have escaped the Fas-mediated checkpoint that normally operates in healthy individuals. Using different biochemical, molecular, and functional approaches, we analyzed the Fas signaling in malignant B cells from seven MALT-type lymphomas that were additionally characterized for the t(11;18)(q21;q21) and four gastric diffuse large B cell lymphomas (DLBL). All DLBLs and three of seven MALT-type lymphomas were resistant to Fas-mediated apoptosis in vitro. Moreover, four of five MALT-type lymphomas analyzed and one of three DLBLs analyzed showed mutations in Fas mRNA transcripts but no loss of heterozygosity in the Fas promotor region. Alternative mechanisms of resistance to apoptosis, such as decreased expression of fas or production of soluble Fas were not operative. Therefore. it is suggestive that a subgroup of MALT-type lymphoma B cells, irrespective of t(11;18)(q21:q21), escape the censoring Fas pathway by mutating and inactivating Fas. This identifies a key regulatory step in early MALT-type lymphomagenesis.
引用
收藏
页码:977 / 986
页数:10
相关论文
共 58 条
[1]   Ligation of CD40 rescues Ramos-Burkitt lymphoma B cells from calcium ionophore- and antigen receptor-triggered apoptosis by inhibiting activation of the cysteine protease CPP32/Yama and cleavage of its substrate PARP [J].
An, SK ;
Knox, KA .
FEBS LETTERS, 1996, 386 (2-3) :115-122
[2]   GROWING HUMAN LYMPHOCYTES-B IN THE CD40 SYSTEM [J].
BANCHEREAU, J ;
ROUSSET, F .
NATURE, 1991, 353 (6345) :678-679
[3]   Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: A molecular and immunological analysis [J].
Bettinardi, A ;
Brugnoni, D ;
QuirosRoldan, E ;
Malagoli, A ;
LaGrutta, S ;
Correra, A ;
Notarangelo, LD .
BLOOD, 1997, 89 (03) :902-909
[4]  
Cascino I, 1996, J IMMUNOL, V156, P13
[5]  
CASCINO I, 1995, J IMMUNOL, V154, P2706
[6]   PROTECTION FROM FAS-MEDIATED APOPTOSIS BY A SOLUBLE FORM OF THE FAS MOLECULE [J].
CHENG, JH ;
ZHOU, T ;
LIU, CD ;
SHAPIRO, JP ;
BRAUER, MJ ;
KIEFER, MC ;
BARR, PJ ;
MOUNTZ, JD .
SCIENCE, 1994, 263 (5154) :1759-1762
[7]   IAP family proteins - suppressors of apoptosis [J].
Deveraux, QL ;
Reed, TC .
GENES & DEVELOPMENT, 1999, 13 (03) :239-252
[8]   IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases [J].
Deveraux, QL ;
Roy, N ;
Stennicke, HR ;
Van Arsdale, T ;
Zhou, Q ;
Srinivasula, SM ;
Alnemri, ES ;
Salvesen, GS ;
Reed, JC .
EMBO JOURNAL, 1998, 17 (08) :2215-2223
[9]   The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas [J].
Dierlamm, J ;
Baens, M ;
Wlodarska, I ;
Stefanova-Ouzounova, M ;
Hernandez, JM ;
Hossfeld, DK ;
De Wolf-Peeters, C ;
Hagemeijer, A ;
Van den Berghe, H ;
Marynen, P .
BLOOD, 1999, 93 (11) :3601-3609
[10]  
Doi T, 1999, J EXP CLIN CANC RES, V18, P343